Pancreatic Cancer Research

ResearcherNankai UniversityActive in the last 2 years

Youjia Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2077-1999; OpenAlex author ID A5001017107. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers

Papers 6

  1. Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.omton.2025.201021↗
  2. Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer. Co-author DOI 10.1136/jitc-2025-013175↗
  3. An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2024.149931↗
  4. OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment. Co-author DOI 10.7150/thno.83495↗
  5. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell… Last author DOI 10.1136/jitc-2021-003809↗
  6. Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.ymthe.2020.10.027↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongkai Zhang · 5 shared papers, 2021–2025 · strength 0.77
  2. Cuizhu Zhang · 4 shared papers, 2021–2025 · strength 0.66
  3. Feilong Zhou · 3 shared papers, 2024–2025 · strength 0.60
  4. Shiyu Liu · 3 shared papers, 2022–2025 · strength 0.45
  5. Jiliang Zhao · 2 shared papers, 2024–2025 · strength 0.41
  6. Ruikun Wang · 3 shared papers, 2021–2023 · strength 0.39
  7. Fan Li · 1 shared paper, 2025 · strength 0.19
  8. Jie Wang · 1 shared paper, 2025 · strength 0.19
  9. Yuanke Li · 1 shared paper, 2025 · strength 0.19
  10. Zhaoyuan Zhang · 1 shared paper, 2025 · strength 0.19
  11. Yuan Wang · 1 shared paper, 2023 · strength 0.13
  12. Wenrui Gao · 1 shared paper, 2023 · strength 0.13
  13. Mingjuan Du · 1 shared paper, 2023 · strength 0.13
  14. Wei Wang · 1 shared paper, 2023 · strength 0.13
  15. Liming Zhang · 1 shared paper, 2021 · strength 0.12
  16. Nianchao Zhang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.